• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS ANGIODYNAMICS / BIO FLO; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS ANGIODYNAMICS / BIO FLO; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number H965440140
Medical Device Problem Code Occlusion Within Device (1423)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 06/02/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
As no lot number was provided, a ship history report (shr) was generated for item number (h965440140) in order to ascertain the last three lots shipped to the reporting hospital in the six months prior to the procedure date.The device history records for the lots obtained through the shr were reviewed for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The march 2016 angiodynamics complaint report was reviewed for the bioflo ports product family and the failure mode "occluded - removed." no adverse trend was indicated.The reported complaint description cannot be confirmed, nor can a root cause be identified, as no sample was returned for evaluation.Angiodynamics process controls in place for this device include 100% aspiration of port valve assemblies at qa incoming.Valve assemblies are then sent back to supplier to be assembled into ports.Pasv valve crack testing: valves are 100% tested for aspiration pressure prior to being assembled into port bodies, and port 100% hydrostatic air test (hat): valves are 100% tested for infusion pressure after being assembled to port bodies.
 
Event or Problem Description
Patient had a bioflo port placed less than a year ago.He responded well to his chemo, had completed his therapy, and was currently just maintaining the port.The infusion nurses were not able to flush it (occluded with an obvious clot), so they decided to send him back to dr.(b)(6) for the removal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANGIODYNAMICS / BIO FLO
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls NY 12801
MDR Report Key5742130
Report Number1317056-2016-00086
Device Sequence Number24422
Product Code LJT
UDI-Device IdentifierH965440140
UDI-PublicH965440140
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K131694
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2016
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberH965440140
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/02/2016
Initial Report FDA Received Date06/22/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-